NCT07190781

Development Platform Construction and Application Promotion of Drug-Eluting Stents for Intracranial Aneurysm Interventional Therapy

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 280 (estimated)
• Sponsor: Xinjian Yang · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study is a post-marketing clinical study of the Lattice Flow-Diverting Dense-Mesh Stent. It plans to enroll 280 patients, who will be treated for unruptured intracranial aneurysms using the Lattice Flow-Diverting Dense-Mesh Stent. Patients will be followed up at 12 months after device implantation, and data including the Raymond classification of the target aneurysms, the occurrence of complications, and whether complications result in neurological deficit symptoms will be collected and assessed. Through the above indicators, the clinical safety and efficacy of the product will be evaluated.

Conditions

• Cerebral Aneurysm Unruptured

Interventions

Type	Name	Description
DEVICE	Flow-Diverting Dense-Mesh Stent	Surface-Modified Flow-Diverting Dense-Mesh Stent for Mid-Term Follow-Up Study of Endovascular Embolization Therapy for Cerebral Aneurysms

Timeline

• Start date: 2022-10-24
• Primary completion: 2022-10-24
• Completion: 2026-12-01
• First posted: 2025-09-24
• Last updated: 2025-09-24

Locations

1 site across 1 country: China